Dynavax Technologies (NASDAQ:DVAX) shares traded -5.04% down during most recent session to reach at the closing price of $21.17. The stock exchanged hands 1.86 Million shares versus average trading capacity of 2.87 Million shares, yielding a market cap of $1.3 Billion. Wall Street analysts covering the stock are projecting that the stock will reach $24.75 within the next 52-weeks. The mean target projections are based on 4 opinions.

Taking a broader look brokerage firms’ analysts on the street with an expectant view have Dynavax Technologies (NASDAQ:DVAX) high price target of $30 and with a conservative view have low price target of $17.

Cantor Fitzgerald “Initiates Coverage On” Dynavax Technologies (NASDAQ:DVAX) in a research note issued to investors on 9/15/17 to Overweight with price target of $24.

Additionally on 7/31/17 RBC Capital “Upgrades” Dynavax Technologies (NASDAQ:DVAX) to Outperform setting price target at $0 and on 4/28/16 RBC Capital “Downgrades” the stock to Sector Perform. Furthermore on 4/27/16 JP Morgan “Downgrades” the stock to Neutral at $22.

On the other hand the company has Relative Strength Index (RSI 14) of 48.42 along with Average True Range (ATR 14) of 1.17, Consequently Dynavax Technologies (NASDAQ:DVAX)’s weekly and monthly volatility is 6.17%, 4.68% respectively. The company’s beta value is at 1.45.

In terms of Buy, Sell or Hold recommendations, Dynavax Technologies (NASDAQ:DVAX) has analysts’ mean recommendation of 1.8. This is according to a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.

According to analysts Dynavax Technologies (NASDAQ:DVAX)’s minimum EPS for the current quarter is at $-0.84 and can go high up to $-0.32. The consensus mean EPS for the current quarter is at $-0.47 derived from a total of 5 estimates from the analysts who have weighed in on projected earnings. However the company reported $-0.9 earnings per share for the same quarter during last year.

Previously Dynavax Technologies (NASDAQ:DVAX) reported $-0.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $-0.45 by $0.04. The company posted an earnings surprise of 8.9%.

Currently Dynavax Technologies (NASDAQ:DVAX)’s shares owned by insiders are 0.41%, whereas shares owned by institutional owners are 61.9%. However the six-month change in the insider ownership was recorded 0%, as well as three-month change in the institutional ownership was recorded -0.23%.

Dynavax Technologies (NASDAQ:DVAX) 52-week high price stands at $24.45 and low price stands at $3.20, its price distance from 52-week high is -13.39% while its distance from 52-week low price is 561.72%. The stock hit its 52-week high on 10/05/17, and 52-week low on 11/14/16.

Dynavax Technologies (NASDAQ:DVAX)’s trailing twelve month revenues are $7.7 Million, whereas its price to sales ratio for the same period is 168.44. Its book value per share for the most recent quarter is $2.83 while its price to book ratio for the same period is 7.48, as for as the company’s cash per share for the most recent quarter is $2.07, however its price to cash per share ratio for the same period is 10.21. The stock has 5 year expected PEG ratio of 0 whereas its trailing twelve month P/E ratio is 0.